Influence of Periodontal Diseases on Vascular Parameters in Patients Suffering of Hypertension

February 16, 2024 updated by: University Hospital, Strasbourg, France

Influence of Periodontal Diseases on Hemodynamic and Molecular Vascular Parameters in Patients Suffering of Hypertension

The aim of this study is to assess the influence of the severity of chronic periodontitis on hemodynamic parameters in hypertensive patients.Secondary purposes of this protocol is to identify evolution of several biomarkers and correlate the clinical situation with oral microflora.

Study Overview

Status

Terminated

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

76

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Strasbourg, France, 67000
        • Service de parodontologie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Will be included men with severe and moderate periodontitis

Description

Inclusion Criteria:

  • -Men- >40 years
  • moderate and severe generalized chronic periodontitis
  • Former diagnosis of hypertension
  • >12 teeth

Exclusion Criteria:

  • >70 years
  • smokers (>10 cig/day)
  • body mass index>30
  • Need of antibioprophylaxis
  • Medical treatment including anti-inflammatory drugs and/or antibiotics
  • Refractory form of hypertension- aggressive periodontitis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
blood and cardiological examination

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Measuring the thickness of the intima-media
Time Frame: 15 days
15 days

Secondary Outcome Measures

Outcome Measure
Time Frame
Evaluation of anatomical changes that may occur at the arterial level
Time Frame: Within 15 days after inclusion
Within 15 days after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Olivier HUCK, MD, CHRU Strasbourg

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2015

Primary Completion (Actual)

February 1, 2024

Study Completion (Actual)

February 1, 2024

Study Registration Dates

First Submitted

July 8, 2014

First Submitted That Met QC Criteria

March 16, 2015

First Posted (Estimated)

March 20, 2015

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 16, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on echo Doppler lower limbs

3
Subscribe